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Background — P-selectin is an adhesion receptor expressed on 
activated platelets and endothelial cells. Its natural ligand, 
P-selectin glycoprotein ligand-1, is expressed on leucocytes and 
the P-selectin/PSGL-1 interaction is involved in leukocyte rolling. 
We have compared the interaction of P-selectin with several low 
molecular weight polysaccharides: fucoidan, heparin and dextran 
sulfate.
Methods — Binding assays were obtained from the interaction of 
the polysaccharides with Sialyl Lewis X and PSGL-1 based constructs 
onto microtiter plates coated with P-selectin. SELDI TOF mass 
spectrometry was performed with anionic chips arrays coated with 
P-selectin in the absence or in the presence of polysaccharides. 
Kd were obtained from surface plasmon resonance experiments 
with immobilized Pselectin constructs, polysaccharides being 
injected in the mobile phase. Human whole blood  ow cytometry 
experiments were performed with  uorescein isothiocyanate 
labelled polysaccharides with or without platelets activators.
Results — The fucoidan prevented P-selectin binding to Sialyl Lewis 
X with an IC50 of 20 nM as compared to 400 nM for heparin and 
>25000 nM for dextran sulfate. It exhibited the highest af nity 
for immobilized Pselectin with a KD of 1.2 nM, two orders of 
magnitude greater than the KD of the other polysaccharides. Mass 
spectrometry evidenced the formation of a complex between 
P-selectin and fucoidan. The intensity of the fucoidan binding 
to platelets was dependent on the level of platelet activation. 
Competition between fucoidan and an anti P-selectin antibody 
demonstrated the speci city of the interaction.
General signi cance — Low molecular weight fucoidan is a promising 
therapeutic agent of natural origin for biomedical applications.
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Vulnerable or high-risk atherosclerotic plaques often exhibit large lipid 
cores and thin  brous caps that can lead to deadly vascular events 
via their rupture. In this study, PEGmicelles that incorporate a Gd-
DTPA amphiphile were used as an MR contrast agent. In an approach 
inspired by lipoproteins, the micelles were functionalized with tyrosine 
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